Leap Therapeutics, Inc.
Hedge Funds Holdings
Last updated:
Leap Therapeutics, Inc.‘s stocks are currently a part of 31 hedge funds’ portfolios, which represents 7.02% of the total amount of its stocks outstanding. This makes up a total of 7.95M shares of Leap Therapeutics, Inc.. Compared to the previous quarter, the number fell by -75.61% or -24.66M shares fewer. As for the holding position changes, 22.58% (7) of current hedge fund investors increased the number of shares held, 29.03% (9) of current holders sold a part of the shares held, and 22.58% (7) closed the holdings completely. 2 hedge funds are new holders of Leap Therapeutics, Inc. stock in Q1 2023, it is 6.45% of total holders.
Hedge funds holding Leap Therapeutics (Q2 2018 – Q1 2023)
| Q2 2018 | 22 |
|---|---|
| Q3 2018 | 23 |
| Q4 2018 | 17 |
| Q1 2019 | 10 |
| Q2 2019 | 12 |
| Q3 2019 | 17 |
| Q4 2019 | 12 |
| Q1 2020 | 22 |
| Q2 2020 | 47 |
| Q3 2020 | 38 |
| Q4 2020 | 47 |
| Q1 2021 | 44 |
| Q2 2021 | 39 |
| Q3 2021 | 62 |
| Q4 2021 | 75 |
| Q1 2022 | 78 |
| Q2 2022 | 68 |
| Q3 2022 | 67 |
| Q4 2022 | 59 |
| Q1 2023 | 31 |
Hedge funds changes in Leap Therapeutics positions (Q2 2018 – Q1 2023)
| Q2 2018 | 7 | 8 | 2 | 4 | 1 |
|---|---|---|---|---|---|
| Q3 2018 | 6 | 9 | 5 | 5 | -2 |
| Q4 2018 | 3 | 7 | 3 | 9 | -5 |
| Q1 2019 | 2 | 6 | 0 | 9 | -7 |
| Q2 2019 | 4 | 4 | 0 | 2 | 2 |
| Q3 2019 | 8 | 3 | 2 | 3 | 1 |
| Q4 2019 | 3 | 1 | 2 | 8 | -2 |
| Q1 2020 | 12 | 4 | 1 | 2 | 3 |
| Q2 2020 | 29 | 12 | 1 | 4 | 1 |
| Q3 2020 | 9 | 14 | 10 | 18 | -13 |
| Q4 2020 | 20 | 12 | 7 | 11 | -3 |
| Q1 2021 | 8 | 11 | 17 | 11 | -3 |
| Q2 2021 | 6 | 5 | 12 | 11 | 5 |
| Q3 2021 | 31 | 16 | 7 | 8 | 0 |
| Q4 2021 | 32 | 19 | 7 | 19 | -2 |
| Q1 2022 | 17 | 23 | 15 | 14 | 9 |
| Q2 2022 | 7 | 19 | 18 | 15 | 9 |
| Q3 2022 | 9 | 18 | 14 | 11 | 15 |
| Q4 2022 | 10 | 13 | 15 | 17 | 4 |
| Q1 2023 | 2 | 7 | 9 | 7 | 6 |
Hedge funds changes in Leap Therapeutics stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 0 | 0 |
|---|---|---|
| Q3 2018 | 0 | 0 |
| Q4 2018 | 0 | 0 |
| Q1 2019 | 962,000 | 0 |
| Q2 2019 | 921,000 | 0 |
| Q3 2019 | 602,000 | 0 |
| Q4 2019 | 576,000 | 0 |
| Q1 2020 | 813,000 | 0 |
| Q2 2020 | 1,075,000 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 974,000 | 0 |
| Q2 2021 | 0 | 0 |
| Q3 2021 | 0 | 0 |
| Q4 2021 | 1,845,000 | 492,000 |
| Q1 2022 | 563,000 | 85,000 |
| Q2 2022 | 411,000 | 39,000 |
| Q3 2022 | 255,000 | 27,000 |
| Q4 2022 | 42,825 | 4,005 |
| Q1 2023 | 68,000 | 0 |